Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

CRISPR Therapeutics AG Filed Acc 0001104659-26-126825

Stakes reported in this filing

Reporting person Shares Of the class
ARK Investment Management LLC 10,056,844 10.40%
Catherine D. Wood 10,056,844 10.40%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…